Furthermore, to confirm the oncogenic role of DLX1 in enzalutamide-resistant PCa, we silenced DLX1 in LNCaP derivative enzalutamide-resistant 42D cells (42D ENZR) (Supplementary Fig. 3d). Here, DLX1 is linked to posterior cortical atrophy.